---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-008027"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:25:45.373397+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health acquires option to purchase PRV-001 patents from Prevacus for 1M shares

## Summary
- Option to buy 100% of worldwide patents to PRV-001 and an Enantiomer from Prevacus.
- Consideration for option: 1,000,000 shares of Odyssey common stock.
- If exercised, asset purchase price: 2M shares for PRV-001, 1M shares for Enantiomer.
- Option exercisable within 180 days of Nov 22, 2022; closing within 90 days after exercise.
- Odyssey will also enter an asset purchase agreement upon exercise.

## SEC filing metadata
- accession: 0001683168-22-008027
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316822008027/0001683168-22-008027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316822008027/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-008027
- JSON: https://secwatch.observer/filing/0001683168-22-008027.json
- Plain text: https://secwatch.observer/filing/0001683168-22-008027.txt

## Key facts
- Material Agreements
  Odyssey Health, Inc. entered into Option to Purchase Intellectual Property Agreement with Prevacus, Inc. (effective 2022-11-21).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Prevacus, Inc.
  - Effective: 2022-11-21
  source text: On November 21, 2022, Odyssey Health, Inc. (the “Company” “Odyssey”) entered into an Option to Purchase Intellectual Property Agreement (the “Option Agreement”) with Prevacus, Inc. (“Prevacus”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316822008027/0001683168-22-008027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.